T cell immunity in hepatitis B and hepatitis C virus infection: implications for autoimmunity

被引:28
作者
Ichiki, Y
He, XS
Shimoda, S
Ishibashi, H
Keeffe, EB
Rossaro, L
Gershwin, ME
机构
[1] Univ Calif Davis, Sch Med, Div Rheumatol Allergy & Clin Immunol, Davis, CA 95616 USA
[2] Kyushu Univ, Grad Sch Med Sci, Higashi Ku, Fukuoka 8128582, Japan
[3] Nagasaki Med Ctr, Clin Res Ctr, Nagasaki 8568562, Japan
[4] Stanford Univ, Med Ctr, Dept Med, Div Gastroenterol & Hepatol, Palo Alto, CA 94304 USA
[5] Univ Calif Davis, Transplant Med Housestaff FAC, Sacramento, CA 95817 USA
关键词
D O I
10.1016/j.autrev.2004.12.003
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
T cells are involved in the pathogenesis of important liver diseases including both autoimmune liver diseases, and viral hepatitis. In addition to playing a crucial role in the control of hepatitis viruses, T cell responses are also responsible for the liver injury during acute and chronic phases of viral hepatitis. In this article, we reviewed current literature on T cell immunity to hepatitis B and C viruses. In addition, antigen presenting cells that are critical for T cell immunity against these viruses are also discussed. This will provide insights to the understanding of T cell immunity in autoimmune liver diseases due to the similar role of T cells in autoimmune liver diseases and viral hepatitis. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:82 / 95
页数:14
相关论文
共 88 条
[1]  
[Anonymous], 1999, J Hepatol, V30, P956
[2]   Impaired dendritic cell maturation in patients with chronic, but not resolved, hepatitis C virus infection [J].
Auffermann-Gratzinger, S ;
Keeffe, EB ;
Levy, S .
BLOOD, 2001, 97 (10) :3171-3176
[3]   Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection [J].
Bain, C ;
Fatmi, A ;
Zoulim, F ;
Zarski, JP ;
Trépo, C ;
Inchauspé, G .
GASTROENTEROLOGY, 2001, 120 (02) :512-524
[4]   HLA CLASS-I-RESTRICTED HUMAN CYTOTOXIC T-CELLS RECOGNIZE ENDOGENOUSLY SYNTHESIZED HEPATITIS-B VIRUS NUCLEOCAPSID ANTIGEN [J].
BERTOLETTI, A ;
FERRARI, C ;
FIACCADORI, F ;
PENNA, A ;
MARGOLSKEE, R ;
SCHLICHT, HJ ;
FOWLER, P ;
GUILHOT, S ;
CHISARI, FV .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (23) :10445-10449
[5]   Liver-infiltrating lymphocytes in end-stage hepatitis C virus: Subsets, activation status, and chemokine receptor phenotypes [J].
Boisvert, J ;
Kunkel, EJ ;
Campbell, JJ ;
Keeffe, EB ;
Butcher, EC ;
Greenberg, HB .
JOURNAL OF HEPATOLOGY, 2003, 38 (01) :67-75
[6]   CYTOTOXIC T-LYMPHOCYTE RESPONSE TO HEPATITIS-C VIRUS-DERIVED PEPTIDES CONTAINING THE HLA A2.1 BINDING MOTIF [J].
CERNY, A ;
MCHUTCHISON, JG ;
PASQUINELLI, C ;
BROWN, ME ;
BROTHERS, MA ;
GRABSCHEID, B ;
FOWLER, P ;
HOUGHTON, M ;
CHISARI, FV .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (02) :521-530
[7]   Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus [J].
Chang, KM ;
Rehermann, B ;
McHutchison, JG ;
Pasquinelli, C ;
Southwood, S ;
Sette, A ;
Chisari, FV .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (09) :2376-2385
[8]   Differential CD4+ and CD8+ T-cell responsiveness in hepatitis C virus infection [J].
Chang, KM ;
Thimme, R ;
Melpolder, JJ ;
Oldach, D ;
Pemberton, J ;
Moorhead-Loudis, J ;
McHutchison, JG ;
Alter, HJ ;
Chisari, FV .
HEPATOLOGY, 2001, 33 (01) :267-276
[9]   Analysis of a successful immune response against hepatitis C virus [J].
Cooper, S ;
Erickson, AL ;
Adams, EJ ;
Kansopon, J ;
Weiner, AJ ;
Chien, DY ;
Houghton, M ;
Parham, P ;
Walker, CM .
IMMUNITY, 1999, 10 (04) :439-449
[10]   Hepatitis C virus (HCV) specific immune responses in anti-HCV positive patients without hepatitis C viraemia [J].
Cramp, ME ;
Carucci, P ;
Rossol, S ;
Chokshi, S ;
Maertens, G ;
Williams, R ;
Naoumov, NV .
GUT, 1999, 44 (03) :424-429